Probiotics L. plantarum and L. curvatus in Combination Alter Hepatic Lipid Metabolism and Suppress Diet-Induced Obesity

Obesity

Volumn 21, Issue 12, 2013, Pages 2571-2578

  Yoo, Sae Rom ^a   Kim, Young Jae ^a   Park, Do Young ^b   Jung, Un Ju ^a   Jeon, Seon Min ^a   Ahn, Young Tae ^c   Huh, Chul Sung ^c   McGregor, Robin ^d   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Yakult Co   (South Korea)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; MESSENGER RNA; PROBIOTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MOUSE; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; LACTOBACILLUS CURVATUS; LACTOBACILLUS PLANTARUM; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL;

LACTOBACILLUS CURVATUS; LACTOBACILLUS PLANTARUM; MUS;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; GENE EXPRESSION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTOBACILLUS; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PROBIOTICS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84889664752     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20428     Document Type: Article

References (40)

1. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
2. Delzenne NM, Neyrinck AM, Backhed F, Cani PD,. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011; 7: 639-646.
3. Ley RE, Turnbaugh PJ, Klein S, Gordon JI,. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
4. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabet Obes Metab 2012; 14: 112-120.
5. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 2010; 5: e9085.
6. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI,. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
7. Backhed F,. Programming of host metabolism by the gut microbiota. Ann Nutr Metab 2011; 58 (Suppl 2): 44-52.
8. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
9. Aronsson L, Huang Y, Parini P, et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010; 5: e13087. doi: 10.1371/journal.pone. 0013087.
10. Xie N, Cui Y, Yin YN, et al. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 2011; 11: 53.
11. Yin YN, Yu QF, Fu N, Liu XW, Lu FG,. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 2010; 16: 3394-3401.
12. Andersson U, Branning C, Ahrne S, et al. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Beneficial Microbes 2010; 1: 189-196.
13. Backhed F, Manchester JK, Semenkovich CF, Gordon JI,. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
14. Chang JH, Shim YY, Cha SK, Chee KM,. Probiotic characteristics of lactic acid bacteria isolated from kimchi. J Appl Microbiol 2010; 109: 220-230.
15. Friedewald WT, Levy RI, Fredrickson DS,. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Bligh EG, Dyer WJ,. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
17. Czubayko F, Beumers B, Lammsfuss S, Lutjohann D, von Bergmann K,. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991; 32: 1861-1867.
18. Nepokroeff CM, Lakshmanan MR, Porter JW,. Fatty-acid synthase from rat liver. Methods Enzymol 1975; 35: 37-44.
19. Ochoa S,. Methods Enzymology (, Colowick SP, Kaplan NO, eds.). Academic Press, New York, 1955.
20. Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P,. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metabol 2005; 49: 54-63.
21. Bieber LL, Markwell MA,. Peroxisomal and microsomal carnitine acetyltransferases. Methods Enzymol 1981; 71 (Pt C): 351-358.
22. Lazarow PB,. Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol 1981; 72: 315-319.
23. Ma X, Hua J, Li Z,. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. JHepatol 2008; 49: 821-830.
24. Esposito E, Iacono A, Bianco G, et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 2009; 139: 905-911.
25. Preiss D, Sattar N,. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115: 141-150.
26. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O,. Fatty acid regulation of hepatic gene transcription. J Nutr 2005; 135: 2503-2506.
27. Everard A, Lazarevic V, Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775-2786.
28. Serino M, Luche E, Gres S, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012; 61: 543-553.
29. Uronis JM AJ, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C,. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 2011; 17: 8.
30. Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008; 22: 2416-2426.
31. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
32. Do GM, Oh HY, Kwon EY, et al. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice. Mol Nutr Food Res 2011; 55 (Suppl 2): S173-S185.
33. Pereira DI, Gibson GR,. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 2002; 37: 259-281.
34. Paik HD, Park JS, Park E,. Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet. Biol Pharmaceut Bull 2005; 28: 1270-1274.
35. Gerard P, Beguet F, Lepercq P, et al. Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion. FEMS Microbiol Ecol 2004; 47: 337-343.
36. Veiga P, Juste C, Lepercq P, Saunier K, Beguet F, Gerard P,. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut. FEMS Microbiol Lett 2005; 242: 81-86.
37. Post SM, Zoeteweij JP, Bos MH, et al. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology 1999; 30: 491-500.
38. Musso G, Gambino R, Cassader M,. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62: 361-380.
39. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
40. Lebeer S, Vanderleyden J, De Keersmaecker SC,. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 2008; 72: 728-764.